Congratulations to Philip M. Farrell, MD, PhD, and Michael J. Rock, MD, who have been awarded $153,944 for their project, “Quality Improvement in Cystic Fibrosis Newborn Screening – Addressing the Sweat Test QNS Problem with a Novel Method.” This project will validate a new, attractive method of performing sweat tests on infants at risk for cystic fibrosis (CF), namely the Cystic Fibrosis Quantum Test (CFQT), developed by PolyChrome Medical, Inc., and in doing so will address one of the most difficult problems in the follow-up component of CF newborn screening, i.e., the failure to complete the screening process in a timely fashion due to collection of an insufficient quantity of sweat (QNS [quantity not sufficient] sweat test result).